These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 27339552)

  • 21. Reliability of AlphaFold2 Models in Virtual Drug Screening: A Focus on Selected Class A GPCRs.
    Alhumaid NK; Tawfik EA
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Dynamic, Split-Luciferase-Based Mini-G Protein Sensor to Functionally Characterize Ligands at All Four Histamine Receptor Subtypes.
    Höring C; Seibel U; Tropmann K; Grätz L; Mönnich D; Pitzl S; Bernhardt G; Pockes S; Strasser A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular interaction fingerprint approaches for GPCR drug discovery.
    Vass M; Kooistra AJ; Ritschel T; Leurs R; de Esch IJ; de Graaf C
    Curr Opin Pharmacol; 2016 Oct; 30():59-68. PubMed ID: 27479316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.
    Daga PR; Polgar WE; Zaveri NT
    J Chem Inf Model; 2014 Oct; 54(10):2732-43. PubMed ID: 25148595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
    Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor.
    Seifert R; Wenzel-Seifert K; Burckstummer T; Pertz HH; Schunack W; Dove S; Buschauer A; Elz S
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1104-15. PubMed ID: 12626648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of HeLa cells to evaluate inverse agonistic activity of antihistamines.
    Mizuguchi H; Ono S; Hattori M; Sasaki Y; Fukui H
    Int Immunopharmacol; 2013 Mar; 15(3):539-43. PubMed ID: 23453703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural Analysis of the Histamine H
    Shiroishi M; Kobayashi T
    Handb Exp Pharmacol; 2017; 241():21-30. PubMed ID: 27826702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Ligand Binding Hot Spots of the Histamine H
    Kuhne S; Kooistra AJ; Bosma R; Bortolato A; Wijtmans M; Vischer HF; Mason JS; de Graaf C; de Esch IJ; Leurs R
    J Med Chem; 2016 Oct; 59(19):9047-9061. PubMed ID: 27643714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in structure, binding sites with ligands and pharmacological function of beta-adrenoceptors obtained by molecular biology and molecular modeling.
    Nagatomo T; Koike K
    Life Sci; 2000; 66(25):2419-26. PubMed ID: 10894084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.
    Govoni M; Bakker RA; van de Wetering I; Smit MJ; Menge WM; Timmerman H; Elz S; Schunack W; Leurs R
    J Med Chem; 2003 Dec; 46(26):5812-24. PubMed ID: 14667234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor.
    Weiss DR; Ahn S; Sassano MF; Kleist A; Zhu X; Strachan R; Roth BL; Lefkowitz RJ; Shoichet BK
    ACS Chem Biol; 2013 May; 8(5):1018-26. PubMed ID: 23485065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ligand-guided homology modeling drives identification of novel histamine H3 receptor ligands.
    Schaller D; Hagenow S; Stark H; Wolber G
    PLoS One; 2019; 14(6):e0218820. PubMed ID: 31237914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current assessment of docking into GPCR crystal structures and homology models: successes, challenges, and guidelines.
    Beuming T; Sherman W
    J Chem Inf Model; 2012 Dec; 52(12):3263-77. PubMed ID: 23121495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of potential dual agonists of FXR and TGR5 using e-pharmacophore based virtual screening.
    Sindhu T; Srinivasan P
    Mol Biosyst; 2015 May; 11(5):1305-18. PubMed ID: 25787676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational mapping of the conformational transitions in agonist selective pathways of a G-protein coupled receptor.
    Bhattacharya S; Vaidehi N
    J Am Chem Soc; 2010 Apr; 132(14):5205-14. PubMed ID: 20235532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unique binding pocket for KW-4679 in the histamine H1 receptor.
    Nonaka H; Otaki S; Ohshima E; Kono M; Kase H; Ohta K; Fukui H; Ichimura M
    Eur J Pharmacol; 1998 Mar; 345(1):111-7. PubMed ID: 9593602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asp73-dependent and -independent regulation of the affinity of ligands for human histamine H
    Hishinuma S; Kosaka K; Akatsu C; Uesawa Y; Fukui H; Shoji M
    Biochem Pharmacol; 2017 Mar; 128():46-54. PubMed ID: 28040476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.